Quality Improvement in Cytology Where Do We Go From Here?

被引:3
作者
Renshaw, Andrew A. [1 ]
机构
[1] Baptist Hosp Miami, Dept Pathol, Miami, FL 33176 USA
关键词
URINE CYTOLOGY; UROVYSION; MALIGNANCY; RISK; CYTOTECHNOLOGISTS; PERFORMANCE; SYSTEM;
D O I
10.5858/arpa.2010-0606-RA
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Cytology is a success because of the many quality controls used to ensure the accuracy of its results. Nevertheless, additional information is becoming available to the cytologist, often from untraditional sources, and the best way to use that information to improve the quality of cytology is not yet known. Objective.-To review ways to use new information to improve the quality of cytology. Data Sources.-Review of relevant literature. Results.-Information contained in many sources can be used in new ways to improve the quality of cytology. These include the timing of cytologic and histologic correlation, electronic medical records, workload information, prior aspirations, and molecular tests. Conclusions.-To maintain their high standard of excellence, cytologists should seek to define the most appropriate way to incorporate this new information into their interpretation of individual cases. (Arch Pathol Lab Med. 2011;135:1387-1390; doi:10.5858/arpa.2010-0606-RA)
引用
收藏
页码:1387 / 1390
页数:4
相关论文
共 50 条
  • [21] Human resource management (HRM) and public service motivation (PSM) Where are we, and where do we go from here?
    Homberg, Fabian
    Vogel, Rick
    INTERNATIONAL JOURNAL OF MANPOWER, 2016, 37 (05) : 746 - 763
  • [22] Stroke prevention in heart failure and sinus rhythm: where do we go from here?
    Vaduganathan, Muthiah
    Patel, Ravi B.
    Yancy, Clyde W.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (10) : 1267 - 1269
  • [23] Where Do We Go from Here?: Globalizing Subsidiaries Moving Up the Value Chain
    Pananond, Pavida
    JOURNAL OF INTERNATIONAL MANAGEMENT, 2013, 19 (03) : 207 - 219
  • [24] Obesity Is Associated With Structural and Functional Brain Abnormalities: Where Do We Go From Here?
    Convit, Antonio
    PSYCHOSOMATIC MEDICINE, 2012, 74 (07): : 673 - 674
  • [25] Themed Issue on the Opioid Epidemic: What Have We Learned? Where Do We Go From Here?
    Benzon, Honorio T.
    Anderson, T. Anthony
    ANESTHESIA AND ANALGESIA, 2017, 125 (05) : 1435 - 1437
  • [26] Basel III: where should we go from here?
    Quang Thi Thieu Nguyen
    JOURNAL OF FINANCIAL ECONOMIC POLICY, 2019, 11 (04) : 457 - 469
  • [27] Using the past to map out the future of occupational health and safety research: where do we go from here?
    Fan, Di
    Zhu, Cherrie Jiuhua
    Timming, Andrew R.
    Su, Yiyi
    Huang, Xinli
    Lu, Ying
    INTERNATIONAL JOURNAL OF HUMAN RESOURCE MANAGEMENT, 2020, 31 (01) : 90 - 127
  • [28] Clinical paradigms and challenges in surface guided radiation therapy: Where do we go from here?
    Batista, Vania
    Meyer, Juergen
    Kugele, Malin
    Al-Hallaq, Hania
    RADIOTHERAPY AND ONCOLOGY, 2020, 153 : 34 - 42
  • [29] Understanding the role of the extracellular matrix in cardiovascular development and disease: Where do we go from here?
    Lindsey, Merry L.
    Borg, Thomas K.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 48 (03) : 431 - 432
  • [30] From Mandated to Test-Optional College Admissions Testing: Where Do We Go from Here?
    Middleton, Kyndra V.
    Omonkhodion, Comfort H.
    Amoateng, Ernest Y.
    Okam, Lucy O.
    Cardoza, Daniela
    Oakley, Alexis
    EDUCATIONAL MEASUREMENT-ISSUES AND PRACTICE, 2024, 43 (04) : 33 - 37